Association between systemic immune-inflammation index and cataract among outpatient US adults

While several studies have noted a higher SII correlates with multiple diseases, research on the association between SII and cataract remains limited. Our cross-sectional study seeks to examine the association between SII and cataract among outpatient US adults. This compensatory cross-sectional stu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in medicine 2024-09, Vol.11, p.1469200
Hauptverfasser: Huang, Jin, Wu, Hongjiang, Yu, Fang, Wu, Fangkun, Hang, Chen, Zhang, Xiaoya, Hao, Yiting, Fu, Hao, Xu, Hongting, Li, Rong, Chen, Ding
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:While several studies have noted a higher SII correlates with multiple diseases, research on the association between SII and cataract remains limited. Our cross-sectional study seeks to examine the association between SII and cataract among outpatient US adults. This compensatory cross-sectional study utilized NHANES data from 1999 to 2008 cycles, conducting sample-weighted multivariate logistic regression and stratified analysis of subgroups. Among 11,205 adults included in this study (5,571 [46.2%] male; 5,634 [53.8%] female), 2,131 (15.2%) had cataract and 9,074 (84.8%) did not have cataract. A fully adjusted model showed that SII higher than 500 × 10 /L was positively correlated with an increased risk of cataracts among women (OR, 1.27; 95% CI, 1.02-1.59) (  = 0.036). However, no difference was found in the men subgroup, and there was no significant interaction between SII and sex. Our results indicated that a SII higher than 500 × 10 /L was positively correlated with an increased risk of cataracts in women. This study is the first to specifically investigate the impact of a high SII on cataract risk in outpatient adults in the United States. By effectively addressing inflammation, it is possible to mitigate cataract progression and significantly enhance patient outcomes.
ISSN:2296-858X
2296-858X
DOI:10.3389/fmed.2024.1469200